COVID-19 and healthcare impacts
COVID-19 and healthcare impacts is a research topic within Oncology. Science Explorer counts 29k research works in it since 1951. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the impact of the COVID-19 pandemic on cancer patients, healthcare systems, and clinical outcomes. It covers topics such as mortality, surgery, delayed diagnosis and treatment, emergency department visits, and the management of cancer care during the pandemic.
- Cancer
- COVID-19
- Pandemic
- Mortality
- Surgery
- Healthcare
- Emergency Department Visits
- Oncology
- Clinical Trials
- Stroke
- Research works
- 29k fractional, since 1951
- In the world top 10%
- 2.9k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -16% the tick is no change
- Largest producer
United States
42% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead COVID-19 and healthcare impacts research?
By volume, the United States and the United Kingdom publish the most (3.4k and 1k works in 2022-now).
By volume, 2022-now
- 1
United States 3.4k works
- 2
United Kingdom 1k works
- 3
India 557 works
- 4
Italy 511 works
- 5
China 508 works
- 6
Brazil 500 works
- 7
Türkiye 472 works
- 8
Canada 430 works
- 9
Spain 364 works
- 10
Germany 331 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead COVID-19 and healthcare impacts research?
By volume in 2022-now, Harvard University publishes the most COVID-19 and healthcare impacts research, followed by University of North Carolina at Chapel Hill and University of Toronto.
By volume, 2022-now
- 1
Harvard University
United States 135 works
- 2
University of North Carolina at Chapel Hill
United States 112 works
- 3
University of Toronto
Canada 89 works
- 4
Sağlık Bilimleri Üniversitesi
Türkiye 58 works
- 5
Johns Hopkins University
United States 56 works
- 6
All India Institute of Medical Sciences
India 53 works
- 7
Mayo Clinic
United States 52 works
- 8
United States Department of Veterans Affairs
United States 46 works
- 9
University College London
United Kingdom 45 works
- 10
Cornell University
United States 39 works
Who are the leading researchers in COVID-19 and healthcare impacts?
The most-cited researchers publishing on COVID-19 and healthcare impacts include David Moher, Ahmedin Jemal and Christopher J L Murray.
- 1
David Moher
Canada 898k citations
- 2
Ahmedin Jemal
United States 761k citations
- 3
Christopher J L Murray
United States 583k citations
- 4
Rebecca L. Siegel
United States 582k citations
- 5
Freddie Bray
France 550k citations
- 6
Jacques Ferlay
France 486k citations
- 7
Rob Knight
United States 468k citations
- 8
Simon Iain Hay
United States 452k citations
- 9
Theo Vos
United States 439k citations
- 10
George Davey Smith
United Kingdom 435k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is COVID-19 and healthcare impacts research done?
The largest centres of COVID-19 and healthcare impacts research in 2022-now are London (United Kingdom), New York (United States), Boston (United States) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in The Bronx and Timișoara.
Largest cities, 2022-now
- 1
London
United Kingdom 291 works
- 2
New York
United States 181 works
- 3
Boston
United States 140 works
- 4
Istanbul
Türkiye 140 works
- 5
Toronto
Canada 133 works
- 6
São Paulo
Brazil 115 works
- 7
Tehran
Iran 111 works
- 8
Chapel Hill
United States 106 works
- 9
Rome
Italy 102 works
- 10
Madrid
Spain 97 works
Where it is the local speciality
- The BronxUS · 23.7 works5.8×
- TimișoaraRO · 21.6 works5.5×
Location quotient: how much more of its research is in COVID-19 and healthcare impacts than the world average.
Where is the best place to study COVID-19 and healthcare impacts?
Among universities, judged by research, Harvard University, University of Toronto and London School of Hygiene & Tropical Medicine score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in COVID-19 and healthcare impacts, country by countryIs COVID-19 and healthcare impacts research growing?
Output in 2022-2025 was 16% lower than in 2018-2021, peaking in 2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is COVID-19 and healthcare impacts as a percentage of every work published that year, 0.039% in 2024.
Fractional works of COVID-19 and healthcare impacts over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about COVID-19 and healthcare impacts. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.